Clinical Trial Update: XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for XB2001 in combination with ONIVYDE and 5-FU/leucovorin in advanced pancreatic cancer; the Phase 1/2 study is listed as active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• Onivyde (irinotecan hydrochloride liposome injection)
• XB2001

Snippet

Sponsor: XBiotech, Inc. | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING